Michael Henderson

Insider Reports History

Entity
Individual
Location
421 Kipling Street, Palo Alto, CA
Signature
/s/ Matthew Batters, as attorney-in-fact for Michael Henderson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Henderson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Chief Executive Officer, Director Common Stock 1.34M $80.3M $59.94 Nov 6, 2024 Direct
Apogee Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 399K Dec 18, 2023 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 11.3K May 14, 2024 Direct
ARYA Sciences Acquisition Corp IV Director Class B ordinary shares 0 Jul 31, 2024 Direct

Insider Reports Filed by Michael Henderson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APGE Apogee Therapeutics, Inc. Nov 6, 2024 2 -$888K 4 Nov 8, 2024 Chief Executive Officer, Director
APGE Apogee Therapeutics, Inc. Oct 2, 2024 2 -$2.25M 4 Oct 4, 2024 Chief Executive Officer, Director
APGE Apogee Therapeutics, Inc. Sep 4, 2024 2 -$1.9M 4 Sep 6, 2024 Chief Executive Officer, Director
APGE Apogee Therapeutics, Inc. Aug 7, 2024 3 -$1.62M 4 Aug 9, 2024 Chief Executive Officer, Director
ARYD ARYA Sciences Acquisition Corp IV Jul 31, 2024 1 $0 4 Jul 31, 2024 Director
APGE Apogee Therapeutics, Inc. Jul 5, 2024 1 -$559K 4 Jul 5, 2024 Chief Executive Officer, Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 1 $0 4 May 16, 2024 Director
APGE Apogee Therapeutics, Inc. Dec 18, 2023 1 $0 4 Dec 20, 2023 Chief Executive Officer, Director
APGE Apogee Therapeutics, Inc. Jul 13, 2023 0 $0 3/A Jul 17, 2023 Chief Executive Officer, Director
AGLE Aeglea BioTherapeutics, Inc. Jun 22, 2023 0 $0 3 Jun 30, 2023 Director